Contribution of endogenously produced reactive oxygen species to the activation of podocyte NLRP3 inflammasomes in hyperhomocysteinemia.
about
Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemiaThe emerging role of the inflammasome in kidney diseasesNlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathyRedox regulation of NLRP3 inflammasomes: ROS as trigger or effector?Inhibition of hyperhomocysteinemia-induced inflammasome activation and glomerular sclerosis by NLRP3 gene deletion.Protective Action of Anandamide and Its COX-2 Metabolite against l-Homocysteine-Induced NLRP3 Inflammasome Activation and Injury in Podocytes.High Prevalence of Hyperhomocysteinemia and Its Association with Target Organ Damage in Chinese Patients with Chronic Kidney Disease.Innate Immune Activity in Glomerular PodocytesRole of inflammasome activation in the pathophysiology of vascular diseases of the neurovascular unit.Energy metabolism and inflammation in brain aging and Alzheimer's disease.Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease.Inflammasome Activation in Chronic Glomerular Diseases.Contribution of guanine nucleotide exchange factor Vav2 to NLRP3 inflammasome activation in mouse podocytes during hyperhomocysteinemia.NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury.Effect of Intravesical Liposome-Based Nerve Growth Factor Antisense Therapy on Bladder Overactivity and Nociception in a Rat Model of Cystitis Induced by Hydrogen Peroxide.Differential effects of short chain fatty acids on endothelial Nlrp3 inflammasome activation and neointima formation: Antioxidant action of butyrate.
P2860
Q34245112-F6CB146A-AA5C-4313-97A8-8EAFD63D7F1AQ34307043-608258F4-9658-4C1C-9B84-AF332D9F0F98Q34836376-3326F364-E2A2-4BAB-A3BB-75A8D655E9C8Q35486035-FD7C28CF-9560-4EE3-88F1-AF59BBCA62BBQ36894381-AB77DEF3-4388-4996-8841-2CF711D664FAQ37062591-FE32AF67-BBDE-4452-BDDC-91619644BC56Q37373971-2855016F-9994-492F-9217-402D83F70660Q37629888-75E471D1-057A-4E76-874A-B926F1B52530Q38256054-FB767135-5860-4F0B-A177-F33E7E7328E5Q38828060-266D7AE7-3D1C-4AC1-9171-C656234E04D3Q38925521-5C0C571A-D448-472A-9362-2A4FCEA395ECQ38931056-CE4A1816-7089-4B0D-BF58-991DF6A90C4EQ45052622-C1290156-FB39-444B-A5F2-197A1FF03A0FQ45057004-DB97D12C-DCFD-43FE-8CFA-47BA1CF9C4DCQ47781573-C7549236-9935-468B-A966-B7B68FDFD979Q55309517-D7A0C268-9F77-479A-B57F-2D4D7D666949
P2860
Contribution of endogenously produced reactive oxygen species to the activation of podocyte NLRP3 inflammasomes in hyperhomocysteinemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Contribution of endogenously p ...... somes in hyperhomocysteinemia.
@en
Contribution of endogenously p ...... somes in hyperhomocysteinemia.
@nl
type
label
Contribution of endogenously p ...... somes in hyperhomocysteinemia.
@en
Contribution of endogenously p ...... somes in hyperhomocysteinemia.
@nl
prefLabel
Contribution of endogenously p ...... somes in hyperhomocysteinemia.
@en
Contribution of endogenously p ...... somes in hyperhomocysteinemia.
@nl
P2093
P2860
P1476
Contribution of endogenously p ...... somes in hyperhomocysteinemia.
@en
P2093
Guangbi Li
Justine M Abais
Krishna M Boini
Pin-Lan Li
Todd W B Gehr
P2860
P304
P356
10.1016/J.FREERADBIOMED.2013.10.009
P577
2013-10-16T00:00:00Z